Codexis (CDXS) News Today $4.33 +0.08 (+1.88%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Codexis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNovember 19 at 4:05 PM | globenewswire.comCodexis' (CDXS) "Overweight" Rating Reiterated at Cantor FitzgeraldNovember 18 at 2:49 AM | americanbankingnews.comStifel Nicolaus Remains a Buy on Codexis (CDXS)November 15, 2024 | markets.businessinsider.comCodexis (CDXS) Receives a Hold from TD CowenNovember 15, 2024 | markets.businessinsider.comCodexis (NASDAQ:CDXS) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $11.00 price objective on shares of Codexis in a report on Friday.November 15, 2024 | marketbeat.comCodexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi TherapeuticsNovember 14, 2024 | globenewswire.comBaillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS)Baillie Gifford & Co. lessened its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 33.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,813,800 shares of the biotechnology company's stocNovember 14, 2024 | marketbeat.comCodexis, Inc.: Codexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNovember 13, 2024 | finanznachrichten.deCodexis Strengthens Board and Updates BylawsNovember 13, 2024 | markets.businessinsider.comCodexis Announces Appointment of Raymond De Vré, PhD, to Board of DirectorsNovember 12, 2024 | globenewswire.comCodexis (CDXS) Gets a Buy from Craig-HallumNovember 12, 2024 | markets.businessinsider.comCodexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi TherapeuticsNovember 11, 2024 | globenewswire.comCodexis Announces New Employment Inducement GrantsNovember 8, 2024 | globenewswire.comabrdn plc Raises Position in Codexis, Inc. (NASDAQ:CDXS)abrdn plc lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 62.5% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 800,410 shares of the biotechnology company's stock after acquiring an additional 307,762 shares during the quartNovember 5, 2024 | marketbeat.comCodexis to Participate in Upcoming Healthcare ConferencesNovember 4, 2024 | globenewswire.comCodexis' (CDXS) Hold Rating Reiterated at BenchmarkBenchmark reissued a "hold" rating on shares of Codexis in a research report on Monday.November 4, 2024 | marketbeat.comCodexis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 3, 2024 | finance.yahoo.comCodexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17November 3, 2024 | finance.yahoo.comCodexis (CDXS) Receives a Buy from Stifel NicolausNovember 1, 2024 | markets.businessinsider.comCodexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ...November 1, 2024 | finance.yahoo.comCodexis Reports Strong Q3 Revenue GrowthNovember 1, 2024 | markets.businessinsider.comCodexis: Hold Rating Amid Mixed Market Position and Future Growth ProspectsNovember 1, 2024 | markets.businessinsider.comCodexis Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS)Assenagon Asset Management S.A. boosted its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 23.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,103,442 shares of the biotechnology company's stock after purchasing an adOctober 31, 2024 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Short Interest UpdateCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 2,000,000 shares, a decrease of 11.5% from the September 30th total of 2,260,000 shares. Based on an average daily trading volume, of 552,700 shares, the short-interest ratio is currently 3.6 days.October 29, 2024 | marketbeat.comCodexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual MeetingOctober 24, 2024 | globenewswire.comCodexis (CDXS) to Post Quarterly Earnings on ThursdayCodexis (NASDAQ:CDXS) will be releasing earnings after the market closes on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634762)October 24, 2024 | marketbeat.comCodexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedCodexis (NASDAQ:CDXS) Stock Crosses Above Two Hundred Day Moving Average - Here's What HappenedOctober 22, 2024 | marketbeat.comCodexis announces employment inducement grantsOctober 15, 2024 | finance.yahoo.comCodexis Announces New Employment Inducement GrantsOctober 14, 2024 | globenewswire.comCodexis to Report Third Quarter 2024 Financial Results on October 31October 10, 2024 | globenewswire.comCodexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...October 9, 2024 | gurufocus.comCodexis secures $31 million to extend cash runwayOctober 4, 2024 | uk.investing.comCodexis appoints new CTO and CFOOctober 4, 2024 | investing.comCodexis (CDXS) Receives a Buy from Craig-HallumOctober 4, 2024 | markets.businessinsider.comCodexis Names Georgia Erbez as CFOOctober 2, 2024 | marketwatch.comCodexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyOctober 2, 2024 | globenewswire.comCodexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciencesOctober 1, 2024 | globenewswire.comNantahala Capital Management LLC Sells 832,256 Shares of Codexis, Inc. (NASDAQ:CDXS)Nantahala Capital Management LLC cut its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 18.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,629,622 shares of the biotechnology company's stock after selling 832,256 shares during theOctober 1, 2024 | marketbeat.comFred Alger Management LLC Has $1.08 Million Stock Position in Codexis, Inc. (NASDAQ:CDXS)Fred Alger Management LLC decreased its holdings in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 31.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 349,490 shares of the biotechnology company'sSeptember 28, 2024 | marketbeat.comOpaleye Management Inc. Buys 5,000 Shares of Codexis, Inc. (NASDAQ:CDXS) StockSeptember 27, 2024 | insidertrades.comOpaleye Management Inc. Expands Stake in Codexis Inc.September 24, 2024 | gurufocus.comOpaleye Management Inc. Purchases 45,000 Shares of Codexis, Inc. (NASDAQ:CDXS) StockSeptember 24, 2024 | insidertrades.comCodexis (NASDAQ:CDXS) Stock Rating Reaffirmed by Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and issued a $11.00 price target on shares of Codexis in a report on Friday.September 20, 2024 | marketbeat.comInsider Buying: Codexis, Inc. (NASDAQ:CDXS) Major Shareholder Purchases 61,000 Shares of StockSeptember 20, 2024 | insidertrades.comOpaleye Management Inc. Acquires 61,000 Shares of Codexis, Inc. (NASDAQ:CDXS) StockCodexis, Inc. (NASDAQ:CDXS - Get Free Report) major shareholder Opaleye Management Inc. purchased 61,000 shares of the stock in a transaction that occurred on Wednesday, September 18th. The shares were purchased at an average price of $3.16 per share, with a total value of $192,760.00. Following the completion of the acquisition, the insider now directly owns 7,380,000 shares in the company, valued at $23,320,800. The purchase was disclosed in a filing with the SEC, which is available through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.September 19, 2024 | marketbeat.comPleasing Signs As A Number Of Insiders Buy Codexis StockSeptember 7, 2024 | finance.yahoo.comCodexis Announces New Employment Inducement GrantsSeptember 6, 2024 | globenewswire.comCodexis to Participate in Upcoming Healthcare ConferencesSeptember 3, 2024 | globenewswire.comCodexis (NASDAQ:CDXS) Rating Reiterated by Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $11.00 price objective on shares of Codexis in a research note on Thursday.August 29, 2024 | marketbeat.com Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO CDXS Media Mentions By Week CDXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼0.180.45▲Average Medical News Sentiment CDXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼82▲CDXS Articles Average Week Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FF News GPRE News REX News WLKP News MYGN News NVAX News INVA News OPK News IRWD News EBS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Codexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXS Stock Alerts